Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2026-01-01 @ 5:53 PM
Study NCT ID:
NCT02066532
Status:
COMPLETED
Last Update Posted:
2023-08-24
First Post:
2014-02-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer
Sponsor:
Dawn L. Hershman
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-14
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-18
First Submit QC Date:
None
Study First Post Date:
2014-02-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-05-04
Results First Submit QC Date:
None
Results First Post Date:
2023-08-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-01
Last Update Post Date:
2023-08-24
Last Update Post Date Type:
ACTUAL